152 related articles for article (PubMed ID: 5119135)
1. [General pharmacology of a new substance derived from cinnamoyl piperazine. II. Action on general circulation and the autonomic nervous system. Other pharmacological properties].
Pourrias B; Dorme N; Bouvet P; Raynaud G
Therapie; 1971; 26(4):859-72. PubMed ID: 5119135
[No Abstract] [Full Text] [Related]
2. [Pharmacodynamic study of a new vasodilatator, cinepazide maleate. II. Action on general and cardiac hemodynamics, respiration and diuresis. Local anesthetic action and effect on the autonomic nervous system. Prolonged toxicity].
Pourrias B; Bailly Y; Sergant M; Bouvet P; Raynaud G
Therapie; 1974; 29(1):43-50. PubMed ID: 4849378
[No Abstract] [Full Text] [Related]
3. [Pharmacological examination of the antibiotic brneomycin].
Gol'dberg LE; Baumshteĭn VE
Antibiotiki; 1967 Feb; 12(2):132-40. PubMed ID: 5590098
[No Abstract] [Full Text] [Related]
4. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacodynamic study of a new cardiovascular drug: 4-(3',4',5'-trimethoxycinnamoyl)-1-(N-isopropylcarbamoylmethyl) piperazine maleate].
Pourrias B; Bouvet P; Raynaud G
Therapie; 1974; 29(2):233-50 passim. PubMed ID: 4849377
[No Abstract] [Full Text] [Related]
6. [General pharmacology of a new substance derived from cinnamoyl piperazine. I. Toxicological study. Action on coronary circulation and on myocardial metabolism].
Pourrias B; Bailly Y; Sergant M; Bouvet P; Raynaud G
Therapie; 1971; 26(4):845-57. PubMed ID: 5119134
[No Abstract] [Full Text] [Related]
7. [Pharmacological study of the antibiotic tavromycetin].
Gol'dberg LE; Baumshteĭn VE
Antibiotiki; 1967 May; 12(5):360-9. PubMed ID: 5593960
[No Abstract] [Full Text] [Related]
8. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological study of the antibiotic sibiromycin].
Iliushina NG; Gol'dberg LE
Antibiotiki; 1970 Jul; 15(7):612-7. PubMed ID: 4320321
[No Abstract] [Full Text] [Related]
10. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
11. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
12. [To the pharmacology of the alkaloid eburnamonine].
Trutneva EA; Berezhinskaia VV
Farmakol Toksikol; 1966; 29(2):171-5. PubMed ID: 6000339
[No Abstract] [Full Text] [Related]
13. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
14. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological properties of peptide derivatives of 5-methoxytrayptamine].
Mashkovskiĭ MD; Polezhaeva AI
Farmakol Toksikol; 1966; 29(2):142-8. PubMed ID: 6000337
[No Abstract] [Full Text] [Related]
16. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.
Akashi A; Hashizume T; Tanaka M; Naka S; Hirohashi M; Kasai Y; Sakurai T; Watanabe K; Tsubokawa M; Kasahara A
Arzneimittelforschung; 1980; 30(3):415-9. PubMed ID: 7387751
[No Abstract] [Full Text] [Related]
17. [On the pharmacology of 2,3-dioxybenzoic acid].
Polukordas G; Repchite M; Skublitskene G
Farmakol Toksikol; 1966; 29(5):594-7. PubMed ID: 5995071
[No Abstract] [Full Text] [Related]
18. General pharmacology of pidotimod and testing for drug interactions.
Manzardo S; Falcone A; Pinzetta A; Ieva G; Coppi G
Arzneimittelforschung; 1994 Dec; 44(12A):1441-7. PubMed ID: 7857339
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological study of rubomycins B and C].
Baumshteĭn VE
Antibiotiki; 1969 Aug; 14(8):730-3. PubMed ID: 5309316
[No Abstract] [Full Text] [Related]
20. Pharmacological properties of n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine, a new non-anticholinergic gastric antisecretory agent.
Bianchetti A; Guarneri L; Biraschi LM; Riva M
Arzneimittelforschung; 1975 Apr; 25(4):580-9. PubMed ID: 239733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
